An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

A new drug combination has offered a ray of hope for men with advanced prostate cancer.According to a research published in ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

Figure 1: Photograph of agarose gel electrophoresis showing PCR-RFLP of BRCA2 and HOXB13 gene mutation mentioned in Table 1. (A) Here P1, P3, and P4 shows the positive results for BRCA2 gene mutation.

Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice, whilst those at lowest risk could safely avoid invasive ...

For Breast Cancer Awareness Month, TODAY's Jill Martin brought together participants to sign up for genetic tests for breast ...